Clinical trials
Phase 2 Diabetes Mellitus, Type 2 trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2017 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 3 |
| Boehringer Ingelheim | 2 |
| Haukeland University Hospital | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Novartis Pharmaceuticals | 1 |
| Tranzyme, Inc. | 1 |
| University Hospital, Aker | 1 |
| University of Tromso | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 11 |
| Diabetes Mellitus | 5 |
| Insulin Resistance | 2 |
| Body Weight | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Dyslipidemias | 1 |
| Endocrine System Diseases | 1 |
| Gastroparesis | 1 |
| Heart Failure | 1 |
| Hyperglycemia | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.